Drugmaker Biocon Ltd. is aiming to become the world’s top supplier of insulin in the coming years, its co-founder Kiran Mazumdar-Shaw said, by capturing growing demand for the critical drug while Big Pharma shifts its focus to other medicines.

More News

Crypto

Bitcoin miner IREN enters Europe with Nostrum acquisition as AI pivot accelerates

Cointelegraph2026.06.16

The acquisition adds about 490 megawatts of secured power in Spain as IREN expands beyond Bitcoin mining and builds its European AI cloud platform.